EcoDrugPlus

Protein Kinase D1

Ensembl ID : ENSMAMG00000000028
Gene Symbol: PRKD1
2 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSMAMG00000019782
Gene Symbol: PRKD3
3 Cross references
201 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSMAMG00000009663
Gene Symbol: PRKD3
2 Cross references
209 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSMAMG00000023263
Gene Symbol: PRKDC
2 Cross references
184 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSMAMG00000006298
Gene Symbol: LOC113135957
2 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta, B

Ensembl ID : ENSMAMG00000017295
Gene Symbol: PTK2BB
3 Cross references
195 Possible Orthologues:

Protein Tyrosine Kinase 2aa

Ensembl ID : ENSMAMG00000015199
Gene Symbol: PTK2AA
2 Cross references
246 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11a

Ensembl ID : ENSMAMG00000011232
Gene Symbol: PTPN11A
3 Cross references
251 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSMAMG00000021327
Gene Symbol: PTPRB
2 Cross references
203 Possible Orthologues:

Protein-Serine O-Palmitoleoyltransferase Porcupine-Like

Ensembl ID : ENSMAMG00000008855
Gene Symbol: LOC113145482
2 Cross references
197 Possible Orthologues:

Proteinase-Activated Receptor 1-Like

Ensembl ID : ENSMAMG00000027882
Gene Symbol: LOC113125013
3 Cross references
263 Possible Orthologues:

Proto-Oncogene Tyrosine-Protein Kinase Src-Like

Ensembl ID : ENSMAMG00000005682
Gene Symbol: LOC113129962
3 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).